首页 | 本学科首页   官方微博 | 高级检索  
   检索      


First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker
Authors:Niels Tørring  Susan Ball  Dave Wright  Gaïané Sarkissian  Marie Guitton  Bruno Darbouret
Institution:1.Department of Clinical Biochemistry,Aarhus University Hospital-Skejby,Aarhus,Denmark;2.Centre for Health and Environmental Statistics,University of Plymouth,Plymouth,UK;3.Research and Development Department,Cezanne SAS, Parc Scientifique Georges Besse,Nimes,France
Abstract:

Background  

A disintegrin and metalloprotease 12 (ADAM12-S) has previously been reported to be significantly reduced in maternal serum from women with fetal aneuploidy early in the first trimester and to significantly improve the quality of risk assessment for fetal trisomy 21 in prenatal screening. The aim of this study was to determine whether ADAM12-S is a useful serum marker for fetal trisomy 21 using the mixture model.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号